Literature DB >> 3964986

Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study.

F N Brand, D L McGee, W B Kannel, J Stokes, W P Castelli.   

Abstract

Uric acid values were obtained on subjects of the original Framingham cohort at their fourth and 13th biennial examinations. The mean uric acid value for men was 5.0 mg/dl at the fourth examination and 5.7 mg/dl at examination 13 and was 3.9 mg/dl and 4.7 mg/dl, respectively, for women. This secular trend was due to both "laboratory drift" and increasing use of diuretics. Serum uric acid values were consistently higher in subjects of both sexes who were taking antihypertensive drugs at both examinations. Serum uric acid values correlated with systolic and diastolic blood pressure in both sexes; the relationship was stronger in women than in men and for systolic than for diastolic pressure. Correlations were stronger at examination 4 than at examination 13 when more antihypertensive treatment was used. Examination 4 serum uric acid predicted the subsequent development of coronary heart disease, in general, and myocardial infarction, in particular, but not angina pectoris. The uric acid relationship with myocardial infarction was equally strong in both sexes, even correcting for antihypertensive treatment. However, in multivariate analysis, including age, systolic blood pressure, relative weight, cigarette smoking, and serum cholesterol, serum uric acid did not add independently to the prediction of coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3964986     DOI: 10.1093/oxfordjournals.aje.a113972

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  71 in total

1.  Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980-1994. National Integrated Projects for Prospective Observation of Non-communicable Diseases and its Trend in the Aged.

Authors:  K Sakata; T Hashimoto; H Ueshima; A Okayama
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 2.  Serum uric acid as a cardiovascular risk factor for heart disease.

Authors:  M H Alderman
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 3.  Serum uric acid is not an independent risk factor for coronary heart disease.

Authors:  S G Wannamethee
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 4.  Hyperuricemia and renal function.

Authors:  L M Ruilope; J Garcia-Puig
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

5.  Characteristics of gouty arthritis in the Guatemalan population.

Authors:  C O Garcia; A G Kutzbach; L R Espinoza
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980

Review 6.  The epidemiology of uric acid and fructose.

Authors:  Young Hee Rho; Yanyan Zhu; Hyon K Choi
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

7.  [Hyperuricemia and gout: diagnosis and therapy].

Authors:  A K Tausche; S Unger; K Richter; C Wunderlich; J Grässler; B Roch; H E Schröder
Journal:  Internist (Berl)       Date:  2006-05       Impact factor: 0.743

Review 8.  Hyperuricemia and cardiovascular risk.

Authors:  Davide Grassi; Giovambattista Desideri; Anna Vittoria Di Giacomantonio; Paolo Di Giosia; Claudio Ferri
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-02-20

9.  Uric acid within the "normal" range predict 9-year cardiovascular mortality in older individuals. The InCHIANTI study.

Authors:  Gloria Brombo; Francesco Bonetti; Stefano Volpato; Mario L Morieri; Ettore Napoli; Stefania Bandinelli; Antonio Cherubini; Marcello Maggio; Jack Guralnik; Luigi Ferrucci; Giovanni Zuliani
Journal:  Nutr Metab Cardiovasc Dis       Date:  2019-06-28       Impact factor: 4.222

10.  Predictors of stroke mortality in elderly people from the general population. The CArdiovascular STudy in the ELderly.

Authors:  A Mazza; A C Pessina; A Pavei; R Scarpa; V Tikhonoff; E Casiglia
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.